Issue 18, 2022

Quantitative brain-derived neurotrophic factor lateral flow assay for point-of-care detection of glaucoma

Abstract

Glaucoma, a ruinous group of eye diseases with progressive degeneration of the optic nerve and vision loss, is the leading cause of irreversible blindness. Accurate and timely diagnosis of glaucoma is critical to promote secondary prevention and early disease-modifying therapies. Reliable, cheap, and rapid tests for measuring disease activities are highly required. Brain-derived neurotrophic factor (BDNF) plays an important role in maintaining the function and survival of the central nervous system. Decreased BDNF levels in tear fluid can be seen in glaucoma patients, which indicates that BDNF can be regarded as a novel biomarker for glaucoma. Conventional ELISA is the standard method to measure the BDNF level, but the multi-step operation and strict storage conditions limit its usage in point-of-care settings. Herein, a one-step and a portable glaucoma detection method was developed based on the lateral flow assay (LFA) to quantify the BDNF concentration in artificial tear fluids. The results of the LFA were analyzed by using a portable and low-cost system consisting of a smartphone camera and a dark readout box fabricated by 3D printing. The concentration of BDNF was quantified by analyzing the colorimetric intensity of the test line and the control line. This assay yields reliable quantitative results from 25 to 300 pg mL−1 with an experimental detection limit of 14.12 pg mL−1. The LFA shows a high selectivity for BDNF and high stability in different pH environments. It can be readily adapted for sensitive and quantitative testing of BDNF in a point-of-care setting. The BDNF LFA strip shows it has great potential to be used in early glaucoma detection.

Graphical abstract: Quantitative brain-derived neurotrophic factor lateral flow assay for point-of-care detection of glaucoma

Supplementary files

Article information

Article type
Paper
Submitted
10 Maijs 2022
Accepted
02 Aug. 2022
First published
02 Aug. 2022
This article is Open Access
Creative Commons BY license

Lab Chip, 2022,22, 3521-3532

Quantitative brain-derived neurotrophic factor lateral flow assay for point-of-care detection of glaucoma

Y. Wu, Y. Hu, N. Jiang, R. Anantharanjit, A. K. Yetisen and M. F. Cordeiro, Lab Chip, 2022, 22, 3521 DOI: 10.1039/D2LC00431C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements